Stay updated on Clinical Trial: SAR650984 Combo in NDMM Non-Transplant Eligible
Sign up to get notified when there's something new on the Clinical Trial: SAR650984 Combo in NDMM Non-Transplant Eligible page.

Latest updates to the Clinical Trial: SAR650984 Combo in NDMM Non-Transplant Eligible page
- Check2 days agoChange DetectedUpgraded from v3.0.1 to v3.0.2. Removed the 'Back to Top' link; no substantive content changes are shown.SummaryDifference0.1%
- Check9 days agoChange DetectedThe web page has been updated to include a new research article on Isatuximab for multiple myeloma patients, indicating a significant addition to the core content. Additionally, the version number has been updated from v3.0.0 to v3.0.1.SummaryDifference2%
- Check17 days agoChange DetectedThe web page has been updated to include a comprehensive list of locations and facilities related to plasma cell myeloma, along with relevant publications from PubMed. Notably, several specific locations and terms have been added, while some previous entries have been removed.SummaryDifference11%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.7%
Stay in the know with updates to Clinical Trial: SAR650984 Combo in NDMM Non-Transplant Eligible
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: SAR650984 Combo in NDMM Non-Transplant Eligible page.